Oncosil Medical Ltd has released a press release.
Proposed issue of Securities - OSL
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from OncoSil Medical
- Oncosil breakthrough device receives CE Marking approval
- Clarification Statement
- Pause in Trading
- FDA Grants Breakthrough Device Designation
- CE Mark Update
Later from OncoSil Medical
- Allotment of Securities under Institutional Placement
- OncoSil receives Singapore regulatory approval
- OncoSil files for TGA registration
- OncoSil presents clinical data at ESMO World Congress
- HDE filing submitted in US for Bile Duct Cancer treatment
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical